POSTN and ovarian cancer: Growing evidence has implicated that POSTN is overexpressed in various types of human cancer tissues, including ovarian cancer [21], breast cancer [22,23], colon cancer [24], head and neck cancer [25], and pancreatic ductal adenocarcinoma [26].